Josephine Kang

2.0k total citations
36 papers, 1.5k citations indexed

About

Josephine Kang is a scholar working on Pulmonary and Respiratory Medicine, Radiation and Surgery. According to data from OpenAlex, Josephine Kang has authored 36 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Pulmonary and Respiratory Medicine, 13 papers in Radiation and 10 papers in Surgery. Recurrent topics in Josephine Kang's work include Advanced Radiotherapy Techniques (13 papers), Prostate Cancer Diagnosis and Treatment (13 papers) and Prostate Cancer Treatment and Research (10 papers). Josephine Kang is often cited by papers focused on Advanced Radiotherapy Techniques (13 papers), Prostate Cancer Diagnosis and Treatment (13 papers) and Prostate Cancer Treatment and Research (10 papers). Josephine Kang collaborates with scholars based in United States, France and Japan. Josephine Kang's co-authors include Alan J. Katz, Martin J. Blaser, Silvia C. Formenti, Sandra Demaria, Alan D. D’Andrea, David Kozono, Shuyan Huang, Rahul Aras, Jim C. Hu and David C. Madoff and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and JNCI Journal of the National Cancer Institute.

In The Last Decade

Josephine Kang

35 papers receiving 1.5k citations

Peers

Countries citing papers authored by Josephine Kang

Since Specialization

Citations

This map shows the geographic impact of Josephine Kang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Josephine Kang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Josephine Kang more than expected).

Fields of papers citing papers by Josephine Kang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Josephine Kang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Josephine Kang. The network helps show where Josephine Kang may publish in the future.

Co-authorship network of co-authors of Josephine Kang

This figure shows the co-authorship network connecting the top 25 collaborators of Josephine Kang. A scholar is included among the top collaborators of Josephine Kang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Josephine Kang. Josephine Kang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	T-cell engaging bispecific outer membrane vesicles (BiTE-OMV) for targeted prostate cancer immunotherapy 2025 ·Journal of Drug Delivery Science and Technology ·Josephine Kang, Kyumin Kim, Shaoqing Ju, (unknown), Jimi Kim, Seunghwan Kim, Byung Seok Kim, Joachim Jose, Jae‐Chul Pyun, Misu Lee, (unknown)	1
2	Natural history of lower urinary tract symptoms among men undergoing stereotactic body radiation therapy for prostate cancer with and without a Rectal Hydrogel Spacer 2022 ·World Journal of Urology ·Mark N. Alshak, (unknown), (unknown), (unknown), (unknown), Himanshu Nagar, Josephine Kang, Bilal Chughtai	4
3	Quantifying the impact of SpaceOAR hydrogel on inter‐fractional rectal and bladder dose during 0.35 T MR‐guided prostate adaptive radiotherapy 2021 ·Journal of Applied Clinical Medical Physics ·Reza Farjam, Sean S. Mahase, (unknown), (unknown), (unknown), (unknown), Bilal Chughtai, J. Keith DeWyngaert, Josephine Kang, (unknown), Himanshu Nagar	5
4	Trends And Disparities In The Diagnosis And Initial Management Of High-Risk Prostate Cancer In The United States 2020 ·International Journal of Radiation OncologyBiologyPhysics ·(unknown), Xiaoyue Ma, Josephine Kang, Jim C. Hu, Christopher E. Barbieri, Himanshu Nagar	2
5	Combining Immunotherapy with Radiotherapy for the Treatment of Genitourinary Malignancies 2018 ·European Urology Oncology ·Abhishek A. Solanki, Alberto Bossi, Jason A. Efstathiou, (unknown), Michele Mondini, Rishab Ramapriyan, James W. Welsh, Josephine Kang	20
6	Radiation Oncology Physician Practice in the Modern Era: A Statewide Analysis of Medicare Reimbursement 2017 ·Cureus ·Johnny Kao, (unknown), (unknown), Andrew T. Wong, Paul J. Christos, Josephine Kang	5
7	Current clinical trials testing the combination of immunotherapy with radiotherapy 2016 ·Journal for ImmunoTherapy of Cancer ·Josephine Kang, Sandra Demaria, Silvia C. Formenti	306
8	Impact of Radiation Therapy on Aggressive Care and Quality of Life Near Death 2016 ·Journal of Pain and Symptom Management ·David Li, Holly G. Prigerson, Josephine Kang, Paul K. Maciejewski	8
9	Predicting Biochemical Disease-Free Survival after Prostate Stereotactic Body Radiotherapy: Risk-Stratification and Patterns of Failure 2016 ·Frontiers in Oncology ·Alan J. Katz, Silvia C. Formenti, Josephine Kang	44
10	Locally ablative therapies for primary and metastatic liver cancer 2014 ·Expert Review of Anticancer Therapy ·(unknown), Josephine Kang, David C. Madoff	33
11	Stereotactic body radiotherapy with or without external beam radiation as treatment for organ confined high-risk prostate carcinoma: a six year study 2014 ·Radiation Oncology ·Alan J. Katz, Josephine Kang	184
12	Quality of Life and Toxicity after SBRT for Organ-Confined Prostate Cancer, a 7-Year Study 2014 ·Frontiers in Oncology ·Alan J. Katz, Josephine Kang	81
13	Stereotactic Body Radiotherapy as Treatment for Organ Confined Low- and Intermediate-Risk Prostate Carcinoma, a 7-Year Study 2014 ·Frontiers in Oncology ·Alan J. Katz, Josephine Kang	70
14	Using a Robotic Stereotactic Radiation Treatment System for Re-Irradiation may be Safe and Effective 2014 ·Rex Cheung, Josephine Kang, Vincent Yeung	1
15	A DNA Repair Pathway–Focused Score for Prediction of Outcomes in Ovarian Cancer Treated With Platinum-Based Chemotherapy 2012 ·JNCI Journal of the National Cancer Institute ·Josephine Kang, Alan D. D’Andrea, David Kozono	120
16	Bacterial populations as perfect gases: genomic integrity and diversification tensions in Helicobacter pylori 2006 ·Nature Reviews Microbiology ·Josephine Kang, Martin J. Blaser	90
17	Antimutator Role of the DNA Glycosylase mutY Gene in Helicobacter pylori 2006 ·Journal of Bacteriology ·Shuyan Huang, Josephine Kang, Martin J. Blaser	38
18	UvrD Helicase Suppresses Recombination and DNA Damage-Induced Deletions 2006 ·Journal of Bacteriology ·Josephine Kang, Martin J. Blaser	33
19	Structural and Functional Divergence of MutS2 from Bacterial MutS1 and Eukaryotic MSH4-MSH5 Homologs 2005 ·Journal of Bacteriology ·Josephine Kang, Shuyan Huang, Martin J. Blaser	53
20	Extensive repetitive DNA facilitates prokaryotic genome plasticity 2003 ·Proceedings of the National Academy of Sciences ·Rahul Aras, Josephine Kang, (unknown), (unknown), Martin J. Blaser	99

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact